Experimental Protocol Sample Clauses

Experimental Protocol. The subject laid supine on a table and his/her MAP was continuously monitored by a finger plethysmograph (Figure 3.1). The finger sensor for MAP measurements was placed on the subject’s middle finger of left hand with his/her left arm fully extended at the same level of the heart. A DCS flowmeter was used to continuously monitoring CBF. A fiber-optic probe containing a multimode source fiber (x 1) and a single mode detector fiber (x 1) was taped on the middle of forehead for CBF measurement. An elastic bandage was used to wrap around the forehead to secure the probe and reduce the influence of room light. The measured light intensity was limited by the use of single- mode fiber for DCS detection, thus restricting the use of large S-D separation. The separation was set at 2.5 cm which allowed for the detection of cerebral hemodynamics in adult prefrontal cortex [25, 38, 61, 63, 64, 68, 108]. The sampling rate for CBF and MAP was 0.64 Hz (1/1.56 s). After baseline measurements for 5 minutes, both thighs of the subject were occluded by two cuff occlusion machines (Aspen ATS1000, Xxxxxx Inc., IN, USA) at a pressure of 230 mm Hg for 5 minutes. The pressures on both thighs were then rapidly and concurrently released.
AutoNDA by SimpleDocs
Experimental Protocol. Relative changes of rCBF, Δ[HbO2], Δ[Hb], and ΔTHC during HUT were monitored by the custom-designed dual-wavelength DCS flow-oximeter. Here “r” denotes the relative change with the unit %, while “Δ” indicates the absolute change in unit of μM. Details about the DCS flow-oximeter can be found in Chapter 2.5. A fiber- optic probe was taped in the middle of forehead at the position of 1 cm above the eyebrows for the optical measurements of cerebral hemodynamic parameters. The separation between source and detector fibers was 2.5 cm. To fix the probe on the frontal head, a self-adhesive elastic band was used to wrap the probe tightly around the forehead. The noninvasive finger plethysmograph (Portapres, FMS Inc., Netherlands) was used to continuously monitor the beat-to-beat MAP in unit of mm Hg and heart rate (HR) in unit of beats-per-minute (BPM). The plethysmograph finger sensor on the middle finger of left hand was maintained at the heart level. Data sampling rate for both optical and MAP/HR measurements is 1 Hz. A 30-minute 70° HUT protocol was adopted in the present study, which is similar to the 10-minute 70° HUT protocol described in Chapter 4. This protocol was selected because previous studies had found that it may induce VVS in healthy subjects [159, 169]. More specifically, the subject was asked to lay supine on a tilt table. To immobilize the body, two Velcro strips were placed over the chest and thighs respectively. Following the supine control for ~10 minutes, the subject was tilted up to 70° and instructed to remain still for 30 minutes if possible. However, when presyncopal symptoms appeared during standing at 70°, the subject was tilted back to supine position immediately for recovery. The recovery period at supine position was ~5 minutes.

Related to Experimental Protocol

  • COVID-19 Protocols Contractor will abide by all applicable COVID-19 protocols set forth in the District’s Reopening and COVID-19 Mitigation Plan and the safety guidelines for COVID-19 prevention established by the California Department of Public Health and the Ventura County Department of Public Health.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Protocol No action to coerce or censor or penalize any negotiation participant shall be made or implied by any other member as a result of participation in the negotiation process.

  • Technology Research Analyst Job# 1810 General Characteristics Maintains a strong understanding of the enterprise’s IT systems and architectures. Assists in the analysis of the requirements for the enterprise and applying emerging technologies to support long-term business objectives. Responsible for researching, collecting, and disseminating information on emerging technologies and key learnings throughout the enterprise. Researches and recommends changes to foundation architecture. Supports research projects to identify and evaluate emerging technologies. Interfaces with users and staff to evaluate possible implementation of the new technology in the enterprise, consistent with the goal of improving existing systems and technologies and in meeting the needs of the business. Analyzes and researches process of deployment and assists in this process.

  • Protocols Each party hereby agrees that the inclusion of additional protocols may be required to make this Agreement specific. All such protocols shall be negotiated, determined and agreed upon by both parties hereto.

  • Product Safety Seller must maintain the state of the product so that it is able to perform to its designed or intended purpose without causing unacceptable risk of harm to a person or damage to property.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Alcohol and Drug Testing Employee agrees to comply with and submit to any Company program or policy for testing for alcohol abuse or use of drugs and, in the absence of such a program or policy, to submit to such testing as may be required by Company and administered in accordance with applicable law and regulations.

  • Department Review If a mutually acceptable solution has not been reached during Step 1, and the employee intends to pursue the grievance formally, the employee shall submit the grievance in writing on the Employee Grievance Resolution Form to the Department Head with a copy to the Labor Relations Division not later than ten (10) working days after the supervisor’s written response. The Department Head shall consider the grievance and render a written decision within ten (10) working days of receipt of the formal grievance. The written decision shall include a clear and concise statement including the reason(s) for the decision. The Department Head may hold a meeting with the employee to achieve any of the following purposes: 1) to identify why the employee feels there is a grievance and facilitate communication and resolution; 2) to clearly identify issues and areas of agreement/disagreement; and 3) to have the parties present whatever available information/ documentation necessary to fully attempt to resolve the grievance. The employee may be accompanied by his/her shop xxxxxxx during the Department Review, provided that the xxxxxxx is in the same department as the employee, and has been identified by the employee on the Employee Grievance Resolution Form. If the department, in consultation with the Labor Relations Division, determines that the grievance is outside of the Department Head’s authority, or the grievance involves employees working in separate departments, then such grievance shall be submitted to Step 3.

Time is Money Join Law Insider Premium to draft better contracts faster.